Aquilo Capital Management as of Dec. 31, 2021
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 53.9 | $475M | 1.0M | 474.96 | |
Spero Therapeutics (SPRO) | 9.0 | $80M | 5.0M | 16.01 | |
Blueprint Medicines (BPMC) | 7.8 | $69M | 646k | 107.11 | |
Arrowhead Pharmaceuticals (ARWR) | 5.3 | $46M | 700k | 66.30 | |
Arvinas Ord (ARVN) | 5.2 | $46M | 564k | 82.14 | |
Regenxbio Inc equity us cm (RGNX) | 3.8 | $33M | 1.0M | 32.70 | |
4d Molecular Therapeutics In (FDMT) | 3.8 | $33M | 1.5M | 21.94 | |
Merus N V (MRUS) | 3.2 | $29M | 897k | 31.80 | |
Amryt Pharma Sponsored Ads | 2.0 | $18M | 1.6M | 10.80 | |
Uniqure Nv SHS (QURE) | 1.6 | $14M | 676k | 20.74 | |
Magenta Therapeutics | 1.6 | $14M | 3.2M | 4.43 | |
Pieris Pharmaceuticals (PIRS) | 1.4 | $12M | 3.2M | 3.78 | |
Argenx Se Sponsored Adr (ARGX) | 0.9 | $7.8M | 22k | 350.18 | |
Genmab A/s Sponsored Ads (GMAB) | 0.6 | $5.0M | 128k | 39.56 |